0001104659-18-019364.txt : 20180321
0001104659-18-019364.hdr.sgml : 20180321
20180321171620
ACCESSION NUMBER: 0001104659-18-019364
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180319
FILED AS OF DATE: 20180321
DATE AS OF CHANGE: 20180321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tursi James Patrick
CENTRAL INDEX KEY: 0001527710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37691
FILM NUMBER: 18705156
MAIL ADDRESS:
STREET 1: 400 ALEXANDER PARK DRIVE
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aralez Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001660719
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 0E4
BUSINESS PHONE: 905-876-1118
MAIL ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 0E4
4
1
a4.xml
4
X0306
4
2018-03-19
0
0001660719
Aralez Pharmaceuticals Inc.
ARLZ
0001527710
Tursi James Patrick
C/O ARALEZ PHARMACEUTICALS INC.,
7100 WEST CREDIT AVENUE, SUITE 101
MISSISSAUGA
A6
L5N 0E4
ONTARIO, CANADA
0
1
0
0
Chief Medical Officer
Common Shares, without par value
2018-03-19
4
S
0
5950
1.70
D
251400
D
This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 15,789 restricted stock units, which were previously granted on March 17, 2016 and which vested on March 17, 2018.
/s/ Eric L. Trachtenberg, attorney-in-fact for James P. Tursi
2018-03-21